Coral Laboratories Balance Sheet Annual

Trade

BSE: 524506 | NSE: - | ISIN: INE683E01017 | Sector: Biotechnology & Drugs

769.00 -10.70 (-1.37%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	61.28	6.13	2.51	2.32
Short Term Investments	25.72	23.88	21.76	19.08
Cashand Short Term Investments	87.00	30.01	24.27	21.41
Accounts Receivable- Trade Net	28.19	23.42	38.11	39.16
Total Receivables Net	33.29	25.63	41.01	39.82
Total Inventory	15.16	12.93	18.79	21.67
Other Current Assets Total	18.41	54.89	46.53	45.60
Total Current Assets	153.85	123.54	130.80	128.62
Property/ Plant/ Equipment Total- Net	23.27	24.28	24.49	20.91
Intangibles Net	0.06	0.02	0.02	0.03
Long Term Investments	27.08	20.54	27.25	16.50
Note Receivable- Long Term	0.35	0.35	0.35	0.35
Other Long Term Assets Total	1.06	5.61	6.98	1.13
Total Assets	205.68	174.35	189.90	167.54
Accounts Payable	13.24	4.21	8.80	14.78
Notes Payable/ Short Term Debt	0.00	0.00	6.04	6.25
Other Currentliabilities Total	11.66	7.65	10.68	6.54
Total Current Liabilities	24.90	11.86	25.52	27.56
Long Term Debt	0.00	-	-	-
Total Long Term Debt	0.00	0.00	0.00	0.00
Total Debt	0.00	0.00	6.04	6.25
Deferred Income Tax	2.57	2.54	2.58	2.52
Other Liabilities Total	0.72	5.15	5.75	0.82
Total Liabilities	28.18	19.55	33.84	30.90
Common Stock Total	3.57	3.57	3.57	3.57
Retained Earnings( Accumulated Deficit)	173.92	151.23	152.48	133.07
Total Equity	177.50	154.80	156.05	136.64
Total Liabilities Shareholders' Equity	205.68	174.35	189.90	167.54
Total Common Shares Outstanding	0.36	0.36	0.36	0.36
Tangible Book Valueper Share Common Eq	496.65	433.24	436.75	382.40
Prepaid Expenses	-	0.09	0.20	0.12
Property/ Plant/ Equipment Total- Gross	-	49.18	47.24	41.62
Accumulated Depreciation Total	-	-24.90	-22.75	-20.71